WHO Meeting on Human Challenge Trials

WHO advisors are meeting today to discuss deliberately infecting young, healthy volunteers with SARS-CoV-2 to hasten vaccine development—despite the promising vaccines already on the way.
Pros: Faster results than conventional vaccine field trials dependent upon participants getting infected over time; they can also compare multiple vaccine candidates—a key consideration since rich nations have already snapped up much of the first vaccines.
Cons: There’s no cure, although there are some promising treatments.
Billed as a “technical consultation with scientific experts,” the meeting is closed to the public—and research participants, which doesn’t sit well with some advocacy groups. Along with a dozen+ scientific experts, possible observers include Wellcome Trust, the Bill & Melinda Gates Foundation, and US NIH and FDA reps.

The Guardian

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top